Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.

Journal of the National Cancer Institute·2026
Same author

ASO Author Reflections: Neuronal Signature Enrichment Distinguishes a Type of Gastric Cancer with Poor Prognosis.

Annals of surgical oncology·2026
Same author

TP53 mutation is associated with shorter treatment duration with CDK4/6 inhibitors, but not with immune checkpoint inhibitors, in ER-positive/HER2-negative breast cancer: real-world perspective.

Breast cancer research : BCR·2026
Same author

BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Pattern of Progression of Oral Potentially Malignant Disorders From Real-World Data: A 24-Year Study.

Head & neck·2026
Same author

Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B-41 Clinical Trial Validation.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Apr 17, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K

Interdigitating dendritic cell sarcoma.

Venkata K Pokuri1, Mihai Merzianu1, Shipra Gandhi1

  • 1From the Department of Medical Oncology and Department of Pathology, Roswell Park Cancer Institute; Department of Medicine, State University of New York; and Department of Head & Neck and Plastic & Reconstructive Surgery, Erie County Medical Center, Buffalo, New York.

Journal of the National Comprehensive Cancer Network : JNCCN
|February 19, 2015
PubMed
Summary

Interdigitating dendritic cell sarcoma (IDCS) is a rare tumor. This case report details a localized IDCS in cervical lymph nodes, reviewing its pathology and treatment.

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
09:04

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

875

Related Experiment Videos

Last Updated: Apr 17, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
09:04

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

875

Area of Science:

  • Oncology
  • Pathology
  • Immunology

Background:

  • Interdigitating dendritic cell sarcoma (IDCS) is an exceptionally rare neoplasm.
  • Fewer than 100 cases are documented in English literature, highlighting its rarity.

Observation:

  • This report presents a case of localized IDCS.
  • The tumor involved the cervical lymph nodes.

Findings:

  • The case study offers a comprehensive literature review.
  • Clinicopathologic features and treatment outcomes of IDCS are analyzed.

Implications:

  • This review contributes to understanding IDCS.
  • It may inform future diagnostic and therapeutic strategies for this rare cancer.